Exploring the latest developments in contained manufacturing

28 May, 2019 | ChargePoint Technology

The highly potent active pharmaceutical ingredient (HPAPI) market is experiencing huge growth; valued at around US$17billion in 2018, it is anticipated to grow to $26 billion by 2023.

As the highly potent active pharmaceutical ingredient (HPAPI) market continues to grow, it is important for manufacturers to establish an effective containment infrastructure. Existing manufacturing facilities are facing mounting pressure due to the growth of the market and the influx of new and reclassified HPAPIs. Performance testing and the use of effective technologies are critical to ensuring both regulatory compliance and employee safety.

In this article our head of solutions engineering, Michael Avraam, speaks to Manufacturing Chemist about single use and smart technologies, as well as the efficiencies and assurances they provide to HPAPI manufacturers.

Full article here